Watch Demo

Greece Cardiovascular Drug Industry Outlook 2022 - 2026

See how Greece Cardiovascular Drug performed compared to key markets such as Germany, Italy and Canada.

Key Market Indicators

Greek beta-blocking medicine sales are set to reach around $72 million by 2026. In 2021, the market was valued at $79.2 million, dropping by 1% year on year. This decrease follows a 3.7% year on year rise since 2003. In the 2021 rankings, Greece came in at 8th place, behind Belgium, which had sales of $79.2 million. Italy, Canada and Australia took 2nd, 3rd and 4th places respectively.

Marketing Banner

Greece Cardiovascular Drug Market Data and Forecasts

How much will Greece Cardiovascular Drug Market grow to 2026?

Forecast: Antiarrhythmic Medicine Use in Greece
Forecast: Renin-Angiotensin System Medicine Sales in Greece
Forecast: Cardiac Glycosides Sales in Greece
Forecast: Antiarrhythmic Medicine Sales in Greece
Forecast: Diuretic Medicine Sales in Greece
More in Cardiovascular Drug Industry for 2028

Improve your Knowledge with the latest Indicators and Trends